[Metabolic effects of oral contraceptives: influence of the dosage and nature of the substance used].
Basdevant
A
A
D001695:Biology; D002319:Cardiovascular System; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003278:Contraceptives, Oral, Hormonal; D003920:Diabetes Mellitus; D004194:Disease; D004617:Embolism; D004703:Endocrine System; D004997:Ethinyl Estradiol; D005193:Family Planning Services; D006728:Hormones; D006973:Hypertension; D008055:Lipids; D010827:Physiology; D011374:Progesterone; D045167:Progesterone Congeners; D011372:Progestins; D013923:Thromboembolism; D013927:Thrombosis; D014652:Vascular Diseases
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003278:Contraceptives, Oral, Hormonal; D006728:Hormones; D008055:Lipids; D045167:Progesterone Congeners; D011372:Progestins; D004997:Ethinyl Estradiol; D011374:Progesterone
Biology; Cardiovascular Effects; Contraception; Contraceptive Agents, Estrogen--complications; Contraceptive Agents, Female--complications; Contraceptive Agents, Progestin; Contraceptive Agents--complications; Contraceptive Methods--side effects; Diabetes Mellitus; Diseases; Embolism; Endocrine System; Ethinyl Estradiol--complications; Family Planning; Hormones; Hypertension; Lipid Metabolic Effects; Lipids; Oral Contraceptives, Low-dose; Oral Contraceptives--side effects; Physiology; Progestational Hormones; Progesterone--complications; Progestins, Low-dose; Thromboembolism; Thrombosis; Vascular Diseases